Education
About Us
Working with TipRanks
Follow Us
El.En. S.p.A. (IT:ELN)
:ELN
Top Page
El.En. S.p.A.
(LSE:ELN)
Rating:71Outperform
Price Target:
€13.50
▲(15.48% Upside)
Positive Factors
Disposal of Chinese subsidiary
The disposal of the Chinese subsidiary Penta Laser Zhejiang is seen as a positive catalyst for the stock, eliminating uncertainty regarding the Chinese assets.
Financial performance
1Q results above expectations across all metrics, with revenue up 8.8% thanks to solid performances in both the medical and industrial divisions.
Medical business growth
The company now has greater exposure to the high-margin, high-growth Medical business, which is beneficial for its core operations.
Negative Factors
Industrial segment decline
The industrial segment, including China, declined by -33%, well below the -9% estimate.
El.En. S.p.A. (ELN) vs. iShares MSCI Italy ETF (EWI)
Market Cap
€914.60M
Dividend Yield1.93%
Average Volume (3M)53.23K
Price to Earnings (P/E)18.0
Beta (1Y)0.94
Revenue Growth-18.26%
EPS Growth6.79%
CountryIT
Employees2,080
SectorTechnology
Sector Strength83
IndustryMedical - Devices
Share Statistics
EPS (TTM)N/A
Shares Outstanding80,227,900
10 Day Avg. Volume38,290
30 Day Avg. Volume53,228
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€14.70Price Target Upside25.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
El.En. S.p.A. Business Overview & Revenue Model
Company DescriptionEL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Europe and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicines, surgery, aesthetics, and art; and laser sources and systems for cutting, welding, marking, and engraving on countless materials. It also provides laser sources that include liquid, solid, semiconductor, and gas; and after-sales services, such as supplying of spare parts, as well as consulting and technical assistance services. The company was founded in 1981 and is headquartered in Calenzano, Italy.
How the Company Makes MoneyEl.En. S.p.A. generates revenue primarily through the sale of its laser systems and related services. The company has multiple key revenue streams, including the sale of industrial laser systems for cutting and welding, medical laser devices for surgical and aesthetic applications, and ongoing maintenance and support services. Additionally, El.En. benefits from partnerships with healthcare providers and industrial manufacturers, which help expand its market reach and enhance its service offerings. The company's focus on research and development also allows it to introduce new products that meet emerging market demands, contributing to its earnings growth.
El.En. S.p.A. Financial Statement Overview
Summary
El.En. S.p.A. displays a solid financial position with strengths in revenue growth and operational efficiency. The company maintains a balanced approach to leverage and demonstrates strong cash flow management. While there are minor concerns regarding the recent dip in revenue, the company is well-positioned in the medical equipment and supplies industry, with potential for sustained growth and profitability.Income Statement
El.En. S.p.A. demonstrates a strong income statement with consistent revenue growth over the years. The gross profit margin has remained robust, indicating efficient production and cost management. While the net profit margin is solid, the slight decrease in revenue in the most recent year indicates a potential challenge in sustaining growth momentum. EBIT and EBITDA margins reflect strong operational efficiency.78
Positive
Balance Sheet
The company's balance sheet is stable with a healthy equity ratio and manageable debt levels. The debt-to-equity ratio suggests prudent leverage, while the return on equity indicates effective use of shareholder funds. However, a slight increase in total liabilities over the years signals a need for careful monitoring of financial health.75
Positive
Cash Flow
El.En. S.p.A. shows impressive cash flow management with a strong free cash flow growth rate, turning from negative to positive in recent years. The operating cash flow to net income ratio is favorable, indicating efficient cash generation relative to profits. The company's ability to generate free cash flow supports its capability to reinvest in growth and service debt.80
Positive
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 400.38M | 565.85M | 692.29M | 673.58M | 571.40M | 408.08M |
| Gross Profit | 177.79M | 238.80M | 252.08M | 243.47M | 206.09M | 135.90M |
| EBITDA | 101.21M | 97.35M | 83.94M | 90.71M | 76.59M | 37.18M |
| Net Income | 27.02M | 51.61M | 48.24M | 55.11M | 45.44M | 20.26M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 740.72M | 719.21M | 735.89M | 650.69M | 470.37M |
| Cash, Cash Equivalents and Short-Term Investments | 157.49M | 157.49M | 135.36M | 165.13M | 182.45M | 123.74M |
| Total Debt | 0.00 | 46.72M | 73.63M | 69.74M | 60.50M | 54.59M |
| Total Liabilities | -410.80M | 329.92M | 343.75M | 379.25M | 362.99M | 229.71M |
| Stockholders Equity | 410.80M | 385.02M | 346.03M | 319.96M | 269.37M | 225.42M |
Cash Flow | ||||||
| Free Cash Flow | 75.02M | 73.61M | -1.14M | -16.31M | 63.35M | 33.62M |
| Operating Cash Flow | 83.07M | 83.07M | 12.22M | 2.12M | 79.48M | 44.13M |
| Investing Cash Flow | 68.68K | 68.68K | -16.97M | -30.15M | -20.23M | -8.73M |
| Financing Cash Flow | -47.99M | -47.99M | -24.79M | 10.35M | -3.51M | -8.66M |
El.En. S.p.A. Technical Analysis
Positive
11.69
Price Trends
11.72
Negative
10.78
Positive
10.65
Positive
Market Momentum
-0.01
Positive
48.21
Neutral
13.89
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:ELN, the sentiment is Positive. The current price of 11.69 is below the 20-day moving average (MA) of 11.82, below the 50-day MA of 11.72, and above the 200-day MA of 10.65, indicating a neutral trend. The MACD of -0.01 indicates Positive momentum. The RSI at 48.21 is Neutral, neither overbought nor oversold. The STOCH value of 13.89 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IT:ELN.
El.En. S.p.A. Peers Comparison
Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | €914.60M | 18.01 | 16.98% | 1.93% | -18.26% | 6.79% | |
61 Neutral | $35.52B | 8.84 | -11.06% | 1.87% | 8.55% | -8.14% | |
| ― | €198.94M | 56.07 | -2.86% | ― | ― | ― | |
| ― | €228.27M | 57.64 | 1.01% | ― | ― | ― | |
| ― | €154.51M | 14.67 | 11.00% | ― | ― | ― | |
71 Outperform | €719.49M | 23.01 | 1.29% | ― | ― | ||
54 Neutral | €341.98M | ― | ― | -1.20% | ― |
* Technology Sector Average
Performance Comparison
IT:ELN
El.En. S.p.A.
11.69
2.33
24.85%
GB:0DUK
Biesse SPA
7.50
-0.63
-7.75%
GB:0E3C
Datalogic SPA
4.38
-1.67
-27.60%
GB:0EKI
Gefran SPA
10.95
2.55
30.36%
IT:AV
Antares Vision SpA
4.77
1.66
53.38%
IT:LUVE
LU-VE SpA
32.60
8.11
33.12%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.